NCT00719888 Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease Status COMPLETED Phase PHASE2
NCT00719836 A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00715247 Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes Status COMPLETED Phase N/A
NCT00667277 Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis Status TERMINATED Phase PHASE2
NCT00665067 Correlative Biomarker Study in Patients With Myeloproliferative Disorders Status COMPLETED Phase N/A
NCT00631462 A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis Status COMPLETED Phase PHASE1
NCT00606437 Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants Status COMPLETED Phase PHASE1
NCT00599547 Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients Status COMPLETED Phase PHASE2
NCT00572897 Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis Status COMPLETED Phase PHASE2
NCT00572065 Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis Status COMPLETED Phase EARLY_PHASE1
NCT00522990 Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias Status TERMINATED Phase PHASE1/PHASE2
NCT00509899 Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00475020 Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome Status COMPLETED Phase PHASE2